Abaperidone

This classification denotes an antipsychotic agent with the molecular formula C25H25FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40755Z8956, chemically known as 7-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3-(hydroxymethyl)-4h-1-benzopyran-4-one but generally known as abaperidone, which bears US NIH Compound Identifier 3037308. Abaperidone most often appears in forms base and hydrochloride. European Medicines Agency schedules Abaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00232MIG. The term ABAPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule abaperidone under HS 29349990 and SITC 51579. As of Q4 2014, ABAPERIDONE remains the US FDA Preferred Term for this commodity. Abaperidone bears US NLM identifiers UMLS ID C0762225 and NCI Concept Code C73280. SMILES: FC1CC2ONC(C3CCN(CC3)CCCOC3CC4OCC(C(=O)C4CC3)CO)C2CC1.